Tirzepatide maintenance dose after weight loss: does it work?

7 min read

Written by: 

Leandra Beabout

Reviewed by: 

Patricia Weiser, PharmD

Updated:  May 07, 2026

Trusted source badge

Reviewed By

Patricia Weiser, PharmD

Patricia Weiser, PharmD, is a licensed pharmacist with more than a decade of clinical experience.

View bio

Key takeaways

  • Tirzepatide is intended to be a long-term treatment for weight loss and management. Stopping it too soon can undermine a weight management plan.

  • Tirzepatide maintenance doses — whether for active weight loss or ongoing weight management — include 5 mg, 10 mg, and 15 mg injected once weekly.

  • A healthcare provider can help determine the best tirzepatide maintenance dose after weight loss based on individual goals, lifestyle, and tolerance of the medication.

Here's what we'll cover

Here's what we'll cover

Key takeaways

  • Tirzepatide is intended to be a long-term treatment for weight loss and management. Stopping it too soon can undermine a weight management plan.

  • Tirzepatide maintenance doses — whether for active weight loss or ongoing weight management — include 5 mg, 10 mg, and 15 mg injected once weekly.

  • A healthcare provider can help determine the best tirzepatide maintenance dose after weight loss based on individual goals, lifestyle, and tolerance of the medication.

If you’ve reached your weight loss goals with tirzepatide (Zepbound or Mounjaro), you might be wondering what comes next. Do you need to stay on tirzepatide to maintain results? And if so, what’s the tirzepatide maintenance dose after weight loss

Research shows that the majority of people who stop taking tirzepatide regain a significant portion of the weight they lost. But there is no one-size-fits-all tirzepatide maintenance dose after weight loss. A healthcare provider can help determine the right maintenance dose for you.

Here’s what we know about tirzepatide dosage after you’ve reached your weight loss goal.

What is a tirzepatide maintenance dose after weight loss?

Typical maintenance doses of tirzepatide are 5 mg, 10 mg, or 15 mg injected once weekly. 

Tirzepatide dosage for weight loss starts at 2.5 mg weekly. The starting dose is meant to help your body get used to the treatment and is not considered a long-term dose for weight maintenance. From there, a healthcare provider may increase the dosage every four weeks — a process known as titration — until reaching a dose that is effective while keeping side effects manageable. Not everyone can tolerate, or needs, the maximum dose of 15 mg. 

Currently, there is no differentiation in tirzepatide maintenance dosage after weight loss versus during active weight loss. According to the prescribing information, weekly doses of 5 mg, 10 mg, and 15 mg are recommended for weight reduction (active weight loss) and long-term weight management.

Some people may stay on the same dosage used for active weight loss, while others may be able to lower their dose and still maintain their body weight. Consult your healthcare provider with any questions about adjusting your tirzepatide dosing schedule after reaching your weight loss goal.

Fastest-working GLP-1 for faster weight loss

How do you know if you’ve lost enough weight? 

Typically, you and your healthcare provider will establish a target weight range before starting a prescription weight loss medication. How much weight can be lost on tirzepatide depends on starting weight, dosage, and other factors — clinical trial data shows that people can lose up to 15%–21% of their starting body weight.

If you’re taking a prescription like Zepbound, Wegovy, or Foundayo, you should already be having regular check-ins with your healthcare provider. Together, you can determine when enough weight has been lost. 

Factors used to determine when enough weight has been lost:

  • Body mass index (BMI). A BMI of 25–29 is considered overweight and a BMI of 30 or higher is considered to indicate having obesity. Calculating BMI is one way to check if weight is in a healthy range.

  • Weight stabilization. A weight loss plateau can mean an adjustment to lifestyle or medication may be needed. But sometimes it simply means that weight loss has naturally slowed because a healthy weight has been reached. 

Reasons for a tirzepatide maintenance dose after weight loss

The main reason to take a maintenance dose of tirzepatide after weight loss is to maintain results. 

Tirzepatide stays in the body for about a month. If you stop taking it after weight loss, the effects that support weight loss — slowed digestion, appetite reduction, and blood sugar stabilization — may slowly fade, as evidenced by study results: 

  • In one clinical trial, people with obesity or overweight who used tirzepatide for about 9 months lost an average of 21% of their body weight. A year later, those who stayed on tirzepatide lost another 5.5% on average and maintained most of their weight loss, while those switched to placebo regained about 14% of their weight. 

  • Ina separate analysis of this trial data, about 82% of people who had already lost weight on tirzepatide regained more than 25% of the weight lost after stopping the medication.

Taking a tirzepatide maintenance dose for ongoing weight management may:

Many people stop weight loss medications too soon. If you’ve met your weight loss goals, talk to your healthcare provider about a tirzepatide maintenance dose that’s right for you.

How to find the right tirzepatide maintenance dose

Working with a healthcare provider is the best way to find the right tirzepatide maintenance dose — a dose that keeps the body from regaining weight without necessarily driving further weight loss. 

Tirzepatide comes in six dosage strengths, three of which are considered maintenance doses: 5 mg, 10 mg, or 15 mg weekly. The right dose depends on response to the medication and tolerance of side effects.

Research on tirzepatide maintenance dosing after weight loss is ongoing. Currently, a clinical study is comparing the effectiveness of 5 mg, 10 mg, and 15 mg doses for weight maintenance in people who have already lost weight on tirzepatide. 

When to transition to a tirzepatide maintenance dose after weight loss

Most people transition to a tirzepatide maintenance dose of 5 mg after at least 4 weeks on the 2.5 mg starter dose. Then, over the next few months, the dose is gradually increased based on how well the drug is working and how well it is tolerated, with 5 mg, 10 mg, or 15 mg used for long-term maintenance.

A maintenance dosage is the recommended dose of a weight loss medicine that has been shown in studies to help people both lose weight and maintain that weight loss over time. It does not necessarily mean a lower dose taken after reaching a goal weight. For Mounjaro and Zepbound, many people continue taking their effective treatment dose long term to help prevent weight regain.

There is no official guidance for when or whether someone should lower their dose or stop taking Mounjaro or Zepbound after weight loss. Decisions about long-term dosing should be made with a healthcare provider and based on factors such as weight stability, side effects, overall health, and long-term treatment goals.

Signs it may be time to discuss a long-term maintenance plan with a healthcare provider include:

  • You have reached a personal or provider-recommended weight loss goal.

  • You have maintained a stable weight for several weeks or months.

  • You have established solid healthy lifestyle habits, such as balanced nutrition, regular physical activity, and consistent routines that support weight management.

  • You want to discuss whether your current tirzepatide dosage is still the best fit for long-term weight management.

Once released, the results of theclinical study may offer insights on when to shift to a maintenance dose after reaching a weight loss goal — or whether it makes sense to continue the same dose used for active weight loss.

For now, continue checking in with your healthcare provider at regular intervals.

Signs a tirzepatide maintenance dose may be working 

The clearest sign that a tirzepatide maintenance dose is working is that weight on the scale stays steady over several weeks or months. Body weight fluctuations of 2–4 pounds over a week or month are normal, but the range should be consistent. 

Other signs that tirzepatide is working at a maintenance dose:

  • Fullness and satisfaction after meals are maintained.

  • Appetite and cravings remain manageable.

  • Insulin and blood sugar levels are staying steady.

Signs a tirzepatide maintenance dose may need to be adjusted 

During the transition from active weight loss to weight management, there are a few signs a tirzepatide maintenance dose may not be right:

  • Weight is consistently climbing (rather than fluctuating 2–4 pounds over a few weeks).

  • Weight is continuing to drop, even though a healthy weight has been reached.

  • Appetite and hunger are difficult to manage.

  • Tirzepatide side effects, such as nausea or constipation, feel intolerable or worse than before.

How to keep weight off on a maintenance dose of tirzepatide

Tirzepatide is meant to be taken alongside a balanced eating plan and regular exercise. Try these lifestyle strategies to help keep weight off while taking a tirzepatide maintenance dose:

Incorporate strength training

Regular exercise is recommended for people taking tirzepatide for weight loss. It’s true that cardio workouts, like jogging or dancing, are great for burning calories. But resistance training with weights or high-intensity interval training can help retain and build lean muscle mass over the long term.

Some ways to add strength training to workouts:

  • Whenever an exercise becomes easy, increase the weight incrementally.

  • Incorporate more bodyweight exercises into a cardio routine.

  • Add simple moves — like pushups, squats, or tricep dips — into a daily routine, such as during commercial breaks while watching TV.

Eat more protein

Protein can boost metabolism so that the body burns more calories, whether at rest or during exercise. It can also promote feelings of fullness compared to the same number of calories from processed, high-carb foods. 

High-protein foods include lean meat and fish, eggs, Greek yogurt, beans, nuts, and tofu. For guidance on how much protein to eat for weight loss, try Ro’s daily protein calculator.

Eat more fiber

In one study, adults who ate more fiber experienced more weight loss over six months than adults who did not prioritize fiber. 

Boost daily intake by ensuring meals and snacks include fiber-rich foods like oats, nuts, seeds, and beans.

Stay hydrated

Sipping sparkling water in place of sugary soda can help reduce calorie intake — but there’s more to it. Research suggests that drinking water right before meals can help support weight loss and weight management. 

Drinking water before or during meals is similar to the concept of volume eating. Essentially, filling the stomach with low-calorie fluids or foods promotes fullness more quickly. 

Prioritize sleep

Good sleep hygiene is an underrated weight management strategy. In one study, adults who typically slept fewer than 6.5 hours per night were instructed to increase their sleep to about 7.5 hours per night. After 2 weeks, their daily caloric intake decreased, leading to weight loss. 

Getting enough sleep — at least 7 hours per night — can support overall well-being and may help with appetite control when cravings arise.

Bottom line

There is no one-size-fits-all tirzepatide maintenance dose after weight loss. Here’s a recap on why maintenance dosage is recommended and how to find the right maintenance dose:

  • Many people who stop tirzepatide regain the weight they lost. Continuing treatment with a maintenance dose can help maintain weight loss.

  • Tirzepatide maintenance doses for active weight loss or weight management are often the same. FDA-approved maintenance dosage is 5 mg, 10 mg, or 15 mg once weekly.

  • Weight management is a long-term commitment.  Tirzepatide and other GLP-1 medications are meant to be used alongside consistent lifestyle changes, such as a healthy eating plan and regular exercise. 

  • Personalized medical guidance is key. Deciding when a healthy weight has been reached and what the right tirzepatide maintenance dose may be are questions for a licensed healthcare provider familiar with your goals, medical history, and health condition.

Frequently asked questions (FAQs)

DISCLAIMER

If you have any medical questions or concerns, please talk to your healthcare provider. The articles on Health Guide are underpinned by peer-reviewed research and information drawn from medical societies and governmental agencies. However, they are not a substitute for professional medical advice, diagnosis, or treatment.

Zepbound Important Safety Information: Read more about serious warnings and safety info.

Mounjaro Important Safety Information: Read more about serious warnings and safety info.

Wegovy Important Safety Information: Read more about serious warnings and safety info.

Foundayo Important Safety Information: Read more about serious warnings and safety info.

GLP-1 Important Safety Information: Read more about serious warnings and safety info.

References

  • Baranwal, N., Yu, P. K., & Siegel, N. S. (2023). Sleep physiology, pathophysiology, and sleep hygiene. Progress in Cardiovascular Diseases, 77, 59–69. doi: 10.1016/j.pcad.2023.02.005. Retrieved from https://pubmed.ncbi.nlm.nih.gov/36841492/

  • Bellicha, A., van Baak, M. A., Battista, F., et al. (2021). Effect of exercise training on weight loss, body composition changes, and weight maintenance in adults with overweight or obesity: An overview of 12 systematic reviews and 149 studies. Obesity Reviews : An Official Journal of the International Association for the Study of Obesity, 22(Suppl 4), e13256. doi: 10.1111/obr.13256. Retrieved from https://pmc.ncbi.nlm.nih.gov/articles/PMC8365736/

  • Bhutani, S., Kahn, E., Tasali, E., & Schoeller, D. A. (2017). Composition of two-week change in body weight under unrestricted free-living conditions. Physiological Reports, 5(13), e13336. doi: 10.14814/phy2.13336. Retrieved from https://pmc.ncbi.nlm.nih.gov/articles/PMC5506524/

  • Horn, D. B., Aronne, L. J., Wharton, S., et al. (2025). Tirzepatide for the Maintenance of Body Weight Reduction: Rationale, Design, and Baseline Characteristics of SURMOUNT-MAINTAIN. Obesity. doi: 10.1002/oby.70014. Retrieved from https://onlinelibrary.wiley.com/doi/full/10.1002/oby.70014

  • Farzam, K. & Patel, P. (2025). Tirzepatide. StatPearls. Retrieved from https://www.ncbi.nlm.nih.gov/books/NBK585056/

  • Gasoyan, H., Schulte, R., Boyer, C. B., et al. (2026). Obesity Treatments and Weight Changes in Clinical Practice After Discontinuation of Semaglutide or Tirzepatide. Diabetes, Obesity & Metabolism. doi: 10.1111/dom.70660. Retrieved from https://dom-pubs.pericles-prod.literatumonline.com/doi/10.1111/dom.70660

  • Hayashi, D., Edwards, C., Emond, J. A., et al. (2023). What Is Food Noise? A Conceptual Model of Food Cue Reactivity. Nutrients, 15(22), 4809. doi: 10.3390/nu15224809. Retrieved from https://pmc.ncbi.nlm.nih.gov/articles/PMC10674813/

  • Horn, D. B., Linetzky, B., Davies, M. J., et al. (2026). Cardiometabolic Parameter Change by Weight Regain on Tirzepatide Withdrawal in Adults With Obesity: A Post Hoc Analysis of the SURMOUNT-4 Trial. JAMA Internal Medicine, 186(2), 157–167. doi: 10.1001/jamainternmed.2025.6112. Retrieved from https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/2841273?

  • Institute of Medicine (US) Subcommittee on Military Weight Management. (2004). Weight Management: State of the Science and Opportunities for Military Programs. Retrieved from https://www.ncbi.nlm.nih.gov/books/NBK221839/

  • Miketinas, D. C., Bray, G. A., Beyl, R. A., Ryan, D. H., Sacks, F. M., & Champagne, C. M. (2019). Fiber Intake Predicts Weight Loss and Dietary Adherence in Adults Consuming Calorie-Restricted Diets: The POUNDS Lost (Preventing Overweight Using Novel Dietary Strategies) Study. The Journal of Nutrition, 149(10), 1742–1748. doi: 10.1093/jn/nxz117. Retrieved from https://pmc.ncbi.nlm.nih.gov/articles/PMC6768815/#sec3

  • Moon, J., & Koh, G. (2020). Clinical Evidence and Mechanisms of High-Protein Diet-Induced Weight Loss. Journal of Obesity & Metabolic Syndrome, 29(3), 166–173. doi: 10.7570/jomes20028. Retrieved from https://pmc.ncbi.nlm.nih.gov/articles/PMC7539343/

  • Quarenghi, M., Capelli, S., Galligani, G., Giana, A., Preatoni, G., & Turri Quarenghi, R. (2025). Weight Regain After Liraglutide, Semaglutide or Tirzepatide Interruption: A Narrative Review of Randomized Studies. Journal of Clinical Medicine, 14(11), 3791. doi: 10.3390/jcm14113791. Retrieved from https://pubmed.ncbi.nlm.nih.gov/40507553/

  • Ryan, D. H., & Yockey, S. R. (2017). Weight Loss and Improvement in Comorbidity: Differences at 5%, 10%, 15%, and Over. Current Obesity Reports, 6(2), 187–194. doi: 10.1007/s13679-017-0262-y. Retrieved from https://pmc.ncbi.nlm.nih.gov/articles/PMC5497590/

  • Sedaghat, G., Montazerifar, F., Keykhaie, M. A., et al. (2021). Effect of pre-meal water intake on the serum levels of Copeptin, glycemic control, lipid profile and anthropometric indices in patients with type 2 diabetes mellitus: a randomized, controlled trial. Journal of Diabetes and Metabolic Disorders, 20(1), 171–177. doi: 10.1007/s40200-020-00724-9. Retrieved from https://pmc.ncbi.nlm.nih.gov/articles/PMC8212309/

  • Tasali, E., Wroblewski, K., Kahn, E.,et al. (2022). Effect of Sleep Extension on Objectively Assessed Energy Intake Among Adults With Overweight in Real-life Settings: A Randomized Clinical Trial. JAMA Internal Medicine, 182, 4. doi:10.1001/jamainternmed.2021.8098. Retrieved from https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/2788694

  • U.S. Food & Drug Administration (FDA). (2026). Prescribing Information: Zepbound (tirzepatide injection, for subcutaneous use. Retrieved from https://www.accessdata.fda.gov/drugsatfda_docs/label/2026/217806s002lbl.pdf

  • Zierle-Ghosh, A. & Jan, A. (2023). Physiology, body mass index. StatPearls. Retrieved from https://www.ncbi.nlm.nih.gov/books/NBK535456/

What’s included

Provider consultation

GLP-1 prescription (if appropriate)

Insurance coverage & paperwork handled

Ongoing care & support

Tools to track progress

Please note: The cost of medication is not included in the Ro Body membership.